Christopher R. Curtin

1.0k total citations
24 papers, 802 citations indexed

About

Christopher R. Curtin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Psychiatry and Mental health. According to data from OpenAlex, Christopher R. Curtin has authored 24 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 5 papers in Psychiatry and Mental health. Recurrent topics in Christopher R. Curtin's work include Diabetes Treatment and Management (9 papers), Epilepsy research and treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Christopher R. Curtin is often cited by papers focused on Diabetes Treatment and Management (9 papers), Epilepsy research and treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Christopher R. Curtin collaborates with scholars based in United States, Belgium and Israel. Christopher R. Curtin's co-authors include Damayanthi Devineni, Shean‐Sheng Wang, David Polidori, Sarah Rusch, L. G. Gisclon, Paul Rothenberg, Joseph Murphy, María J. Gutiérrez, Jaya Natarajan and R. Rex Williams and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Epilepsia and Clinical Pharmacology & Therapeutics.

In The Last Decade

Christopher R. Curtin

20 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher R. Curtin United States 13 284 232 190 190 185 24 802
Ganesh Cherala United States 18 82 0.3× 106 0.5× 105 0.6× 230 1.2× 40 0.2× 45 1.0k
Anup Majumdar United States 20 38 0.1× 388 1.7× 538 2.8× 147 0.8× 84 0.5× 49 1.3k
Kyle Matschke United States 15 95 0.3× 83 0.4× 64 0.3× 57 0.3× 40 0.2× 60 545
Yuhki Sato Japan 15 52 0.2× 153 0.7× 143 0.8× 97 0.5× 46 0.2× 78 762
Robert M. Stote United States 14 93 0.3× 130 0.6× 107 0.6× 77 0.4× 42 0.2× 25 702
Chandrahas Sahajwalla United States 14 64 0.2× 118 0.5× 76 0.4× 169 0.9× 40 0.2× 44 771
Takafumi Kuzuya Japan 16 37 0.1× 154 0.7× 183 1.0× 131 0.7× 51 0.3× 43 716
Nicole Vaccaro United States 17 619 2.2× 171 0.7× 408 2.1× 38 0.2× 26 0.1× 25 945
Joelle Campestrini United States 16 415 1.5× 64 0.3× 272 1.4× 96 0.5× 74 0.4× 29 776
In‐Jin Jang South Korea 14 68 0.2× 146 0.6× 70 0.4× 123 0.6× 91 0.5× 27 660

Countries citing papers authored by Christopher R. Curtin

Since Specialization
Citations

This map shows the geographic impact of Christopher R. Curtin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. Curtin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. Curtin more than expected).

Fields of papers citing papers by Christopher R. Curtin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. Curtin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. Curtin. The network helps show where Christopher R. Curtin may publish in the future.

Co-authorship network of co-authors of Christopher R. Curtin

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. Curtin. A scholar is included among the top collaborators of Christopher R. Curtin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. Curtin. Christopher R. Curtin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Curtin, Christopher R., et al.. (2023). Clinician Acceptability of a Peripheral Intravenous Passive Safety Catheter with Blood Control: Practical Use Article. Journal of the Association for Vascular Access. 28(3). 20–29.
2.
Oropallo, Alisha, et al.. (2021). Quality of life improvement in patients with hard-to-heal leg wounds treated with Prontosan wound irrigation solution and wound gel. Journal of Wound Care. 30(10). 854–865. 6 indexed citations
3.
Curtin, Christopher R., et al.. (2018). Types and Frequency of Infusion Pump Alarms: Protocol for a Retrospective Data Analysis. JMIR Research Protocols. 7(6). e10446–e10446. 2 indexed citations
4.
Devineni, Damayanthi, David Polidori, Christopher R. Curtin, et al.. (2015). Single-dose Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Selective Inhibitor of Sodium Glucose Cotransporter 2, in Healthy Indian Participants. Clinical Therapeutics. 38(1). 89–98.e1. 12 indexed citations
5.
Chen, Xia, Pei Hu, Nicole Vaccaro, et al.. (2015). Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Canagliflozin in Healthy Chinese Subjects. Clinical Therapeutics. 37(7). 1483–1492.e1. 25 indexed citations
6.
Devineni, Damayanthi, Christopher R. Curtin, Thomas Marbury, et al.. (2015). Effect of Hepatic or Renal Impairment on the Pharmacokinetics of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor. Clinical Therapeutics. 37(3). 610–628.e4. 39 indexed citations
7.
Devineni, Damayanthi, David Polidori, Christopher R. Curtin, et al.. (2015). Pharmacokinetics and pharmacodynamics of once- and twice-daily multiple-doses of canagliflozin, a selective inhibitor of sodium glucose co-transporter 2, in healthy participants. International Journal of Clinical Pharmacology and Therapeutics. 53(6). 438–446. 16 indexed citations
8.
Manitpisitkul, Prasarn, Christopher R. Curtin, Kevin Shalayda, et al.. (2014). Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment. Epilepsy Research. 108(5). 891–901. 20 indexed citations
9.
Manitpisitkul, Prasarn, Christopher R. Curtin, Kevin Shalayda, et al.. (2014). Pharmacokinetic interactions between topiramate and pioglitazone and metformin. Epilepsy Research. 108(9). 1519–1532. 19 indexed citations
10.
Devineni, Damayanthi, Christopher R. Curtin, David Polidori, et al.. (2013). Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co‐Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus. The Journal of Clinical Pharmacology. 53(6). 601–610. 168 indexed citations
11.
Manitpisitkul, Prasarn, Christopher R. Curtin, Kevin Shalayda, et al.. (2013). An Open-Label Drug–Drug Interaction Study of the Steady-State Pharmacokinetics of Topiramate and Glyburide in Patients with Type 2 Diabetes Mellitus. Clinical Drug Investigation. 33(12). 929–938. 2 indexed citations
12.
Gisclon, L. G., Angela Bowen, Terry O’Reilly, et al.. (2011). Bioequivalence of a Newly Developed 17β-Estradiol Tablet versus an Identical Reference Formulation. Arzneimittelforschung. 50(10). 910–914.
13.
Bialer, Meir, Dennis R. Doose, Bindu Murthy, et al.. (2004). Pharmacokinetic Interactions of Topiramate. Clinical Pharmacokinetics. 43(12). 763–780. 132 indexed citations
14.
Sachdeo, Rǎjesh C., René H. Levy, Anthony J. Streeter, et al.. (2002). Topiramate and Phenytoin Pharmacokinetics During Repetitive Monotherapy and Combination Therapy to Epileptic Patients. Epilepsia. 43(7). 691–696. 50 indexed citations
15.
Gisclon, L. G., et al.. (2000). Lack of Effect of a High‐Fat Meal on the Bioavailability of 17β‐Estradiol/Norgestimate in Healthy Postmenopausal Women. The Journal of Clinical Pharmacology. 40(7). 762–769. 1 indexed citations
16.
Gisclon, L. G., Christopher R. Curtin, Cynthia L. Fowler, et al.. (1997). Absence of a Pharmacokinetic Interaction Between Intravenous Theophylline and Orally Administered Levofloxacin. The Journal of Clinical Pharmacology. 37(8). 744–750. 22 indexed citations
17.
Chien, Shuchean, Mark Rogge, L. G. Gisclon, et al.. (1997). Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses. Antimicrobial Agents and Chemotherapy. 41(10). 2256–2260. 189 indexed citations
18.
Gisclon, L. G., Keith Wesnes, Christopher R. Curtin, et al.. (1996). Incremental dosage of the new antipsychotic mazapertine induces tolerance to cardiovascular and cognitive effects in healthy men*. Clinical Pharmacology & Therapeutics. 59(6). 675–685. 6 indexed citations
19.
Curtin, Christopher R., et al.. (1994). Display technologies in Russia, Ukraine, and Belarus.
20.
Curtin, Christopher R., et al.. (1982). Collusion Practices in a West of Ireland Livestock Mart. Ethnology. 21(4). 349–349. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ganesh Cherala Breakdown of academic impact, for papers by Anup Majumdar Breakdown of academic impact, for papers by Kyle Matschke Breakdown of academic impact, for papers by Yuhki Sato Breakdown of academic impact, for papers by Robert M. Stote Breakdown of academic impact, for papers by Chandrahas Sahajwalla Breakdown of academic impact, for papers by Takafumi Kuzuya Breakdown of academic impact, for papers by Nicole Vaccaro Breakdown of academic impact, for papers by Joelle Campestrini Breakdown of academic impact, for papers by In‐Jin Jang
Rankless by CCL
2026